|
週次 |
日期 |
單元主題 |
|
第1週 |
9/10 |
轉譯醫學：臨床2期失敗率高的主因
Translation Medicine: the key to improve clinical phase 2 success rate
|
|
第2週 |
9/17 |
新藥研發之藥毒理面面觀
Pharmacology / Toxicology in New Drug Development
|
|
第3週 |
9/24 |
蛇毒研究與藥物研發
Snake Venom Research and New Drug Development
|
|
第4週 |
10/01 |
新藥開發漫漫長路
A long journey of drug discovery :
The alpha6 subunit-containing GABAA Receptor modulator as a novel target for neuropsychiatric disorders
|
|
第5週 |
10/08 |
以非受體酪氨酸激酶為標靶之新藥發展
Non-receptor tyrosine kinases as new drug targets
|
|
第6週 |
10/15 |
由基礎研究至轉譯醫學
From basic research to translational medicine
|
|
第7週 |
10/22 |
幹細胞與細胞藥物之發展
Stem cells and cell drug development
|
|
第8週 |
10/29 |
DNA損傷反應於疾病治療的啟示
Therapeutic Implications of the DNA Damage Response
|
|
第9週 |
11/05 |
人類誘導式幹細胞做心血管疾病模擬及精準醫學
Human induced pluripotent stem cell for disease modeling and precision medicine
|
|
第10週 |
11/12 |
基因體學於藥物研發之應用
Genetic and Genomic Approach of Drug Discovery
|
|
第11週 |
11/19 |
免疫治療進展
Development in Immunotherapy
|
|
第12週 |
11/26 |
新藥開發上市相關法規
Regulation of New Drug Approval |
|
第13週 |
12/03 |
中樞神經的藥物遞送發展及病毒載體療法
Drug delivery and viral-based therapy to the central nervous system
|
|
第14週 |
12/10 |
誘導性多功能幹細胞於癌症治療及抗癌藥物開發之應用
Induced Pluripotent Stem Cell as a New Tool for Cancer Therapy and Anti-cancer Drug Discovery
|
|
第16週 |
12/24 |
新藥上市後的挑戰
Challenges after marketing in new drugs
|
|
第17週 |
12/31 |
精準的個體化新藥研發：分子影像
Precise and Individualized New Drug Discovery and Development: Molecular Imaging
|